127 related articles for article (PubMed ID: 36404234)
1. Highly dynamic changes of regional HBV epidemiology over two decades.
Ricco G; Coco B; Colombatto P; Oliveri F; Cavallone D; Bleve P; Vianello B; Romagnoli V; Salvati A; Surace L; Bonino F; Brunetto MR
Dig Liver Dis; 2023 Apr; 55(4):519-526. PubMed ID: 36404234
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
3. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination.
Brancaccio G; Coco B; Nardi A; Quaranta MG; Tosti ME; Ferrigno L; Cacciola I; Messina V; Chessa L; Morisco F; Milella M; Barbaro F; Ciancio A; Russo FP; Coppola N; Blanc P; Claar E; Verucchi G; Puoti M; Zignego AL; Chemello L; Madonia S; Fagiuoli S; Marzano A; Ferrari C; Lampertico P; Di Marco V; Craxì A; Santantonio TA; Raimondo G; Brunetto MR; Gaeta GB; Kondili LA;
Int J Infect Dis; 2023 Apr; 129():266-273. PubMed ID: 36791877
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and clinical management of HIV-HBV coinfected patients in a large AIDS Reference Center in Belgium.
Farid Y; Martin C; Delforge M; De Wit S
Acta Clin Belg; 2019 Dec; 74(6):424-429. PubMed ID: 30513065
[No Abstract] [Full Text] [Related]
5. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
6. The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort.
Brancaccio G; Nardi A; Madonia S; Fasano M; Verucchi G; Massari M; Maimone S; Contini C; Levantesi F; Alfieri A; Gavrila C; Andreone P; Milella M; Gaeta GB
Dig Liver Dis; 2019 Mar; 51(3):438-442. PubMed ID: 30314950
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects.
De Paschale M; Manco MT; Belvisi L; Brando B; Latella S; Agrappi C; Mirri P; Gatti A; Clerici P
Blood Transfus; 2012 Jul; 10(3):344-50. PubMed ID: 22682333
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B. Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum.
Lindh G
Scand J Infect Dis Suppl; 1986; 50():1-45. PubMed ID: 3468608
[TBL] [Abstract][Full Text] [Related]
9. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
[TBL] [Abstract][Full Text] [Related]
11. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
Li J; Sun X; Fang J; Wang C; Han G; Ren W
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
[TBL] [Abstract][Full Text] [Related]
12. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B.
Karataylı SC; Bozdayı M; Karataylı E; Öztürk T; Husseini AA; Albayrak R; Özkan M; Kalaylıoğlu Z; Yalçın K; Çınar K; İdilman R; Yurdaydın C
Liver Int; 2015 Mar; 35(3):846-53. PubMed ID: 24840315
[TBL] [Abstract][Full Text] [Related]
14. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
Heidrich B; Serrano BC; Idilman R; Kabaçam G; Bremer B; Raupach R; Önder FO; Deterding K; Zacher BJ; Taranta A; Bozkaya H; Zachou K; Tillmann HL; Bozdayi AM; Manns MP; Yurdaydın C; Wedemeyer H
Liver Int; 2012 Oct; 32(9):1415-25. PubMed ID: 22716112
[TBL] [Abstract][Full Text] [Related]
15. Detection of occult hepatitis B virus infection among subjects with isolated hepatitis B core antibodies: Results from a 3-year survey in an Italian tertiary-care hospital.
De Conto F; Buttrini M; Dell'Anna ML; Maccari C; Montanari G; Arcangeletti MC; Martinelli M; Chezzi C; Calderaro A
Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101892. PubMed ID: 35202845
[TBL] [Abstract][Full Text] [Related]
16. [Natural history and disease progression of chronic hepatitis B virus infection].
Wang LJ; Li MW; Liu YN; Chen XM; Zhao JM; Liu SH; Lu FM
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):920-926. PubMed ID: 36241234
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HBV, HDV, HCV, and HIV infection during pregnancy in northern Benin.
De Paschale M; Ceriani C; Cerulli T; Cagnin D; Cavallari S; Ndayaké J; Zaongo D; Priuli G; Viganò P; Clerici P
J Med Virol; 2014 Aug; 86(8):1281-7. PubMed ID: 24777580
[TBL] [Abstract][Full Text] [Related]
18. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years.
Kondili LA; Cuko L; Chionne P; Candido A; Madonna E; Dentico P; Resuli B; Taliani G; Brunetto MR; Rapicetta M
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):167-71. PubMed ID: 19734797
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
Gheorghe L; Csiki IE; Iacob S; Gheorghe C; Trifan A; Grigorescu M; Motoc A; Suceveanu A; Curescu M; Caruntu F; Sporea I; Brisc C; Rogoveanu I; Cerban R; Tugui L; Alexandrescu A
J Gastrointestin Liver Dis; 2015 Dec; 24(4):413-21. PubMed ID: 26697566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
